Results summary | View all lists in GO:BiolProc | View all genes in C05AA.profile.ud50 |
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. enrichment: 1.91-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
214786_AT | MAP3K1 | G | X | P | S | ![]() |
![]() |
mitogen-activated protein kinase kinase kinase 1 | |||||
215073_S_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
203140_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
217997_AT | PHLDA1 | G | ![]() |
![]() |
pleckstrin homology-like domain, family A, member 1 | ||||||||
212501_AT | CEBPB | G | D | X | P | R | ![]() |
![]() |
CCAAT/enhancer binding protein (C/EBP), beta | ||||
215990_S_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
203373_AT | SOCS2 | G | S | ![]() |
![]() |
suppressor of cytokine signaling 2 | |||||||
209304_X_AT | GADD45B | G | D | X | S | ![]() |
![]() |
growth arrest and DNA-damage-inducible, beta | |||||
212593_S_AT | PDCD4 | G | R | ![]() |
![]() |
programmed cell death 4 (neoplastic transformation inhibitor) | |||||||
221009_S_AT | ANGPTL4 | G | D | X | E | S | ![]() |
![]() |
angiopoietin-like 4 | ||||
205409_AT | FOSL2 | R | ![]() |
![]() |
FOS-like antigen 2 | ||||||||
201324_AT | EMP1 | G | D | ![]() |
![]() |
epithelial membrane protein 1 | |||||||
37152_AT | PPARD | G | T | D | E | R | C | S | ![]() |
![]() |
peroxisome proliferator-activated receptor delta | ||
205067_AT | IL1B | G | X | P | C | S | ![]() |
![]() |
interleukin 1, beta | ||||
209120_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
211833_S_AT | BAX | G | T | D | X | P | S | ![]() |
![]() |
BCL2-associated X protein |